FDA Classifies September Chlorthalidone Recall as Class II
सिर्फ तथ्य

FDA Classifies September Chlorthalidone Recall as Class II

सारांश

The FDA has designated a September recall of Inventia Healthcare's chlorthalidone tablets as a Class II recall, citing failed dissolution specifications.

Inventia Healthcare announced a recall of a lot of chlorthalidone tablets in early September, adding to a previous June recall of the same medication. On September 17, the U.S. Food and Drug Administration classified the September recall as a Class II recall, the same classification applied to the June recall.

Chlorthalidone, a diuretic used to manage high blood pressure, is being recalled because the tablets failed to meet dissolution specifications, meaning the active ingredient may not dissolve properly for absorption. The FDA notes that a Class II recall indicates that health issues from exposure are unlikely to be serious and are generally reversible.

The recall involves more than 13,000 bottles labeled as 25 mg tablets, 100 per bottle, manufactured by Inventia Healthcare Limited (NDC 64980-599-01, batch RISA24002, expiration 04/2027). Patients are advised to verify the label details and contact their pharmacist if uncertain.

"Patients should contact their healthcare provider before stopping the medication and report any symptoms promptly," the FDA guidance advises.

The agency has not provided additional details on the cause of the dissolution failure.

स्रोत

AOL.com

पढ़ते रहें — निःशुल्क

समाचार फ़ॉलो करने के लिए मुफ़्त खाता बनाएँ। कार्ड की आवश्यकता नहीं।